{{Rsnum
|rsid=275651
|Gene=AGTR1
|Chromosome=3
|position=148697100
|Orientation=plus
|GMAF=0.1791
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=AGTR1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 61.7 | 33.3 | 5.0
| HCB | 71.1 | 20.0 | 8.9
| JPT | 63.6 | 31.8 | 4.5
| YRI | 54.8 | 37.1 | 8.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 71.1 | 20.0 | 8.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs275651
|Name_s=
|Gene_s=RPL38P1, AGTR1
|Feature=NA, NA
|Evidence=PubMed ID:20712529
|Annotation=Risk or phenotype-associated allele: T. Homozygotes for the common allele (TT) had reduced HR for cardiac events while treated with perindopril. Study size: 8907. Study population/ethnicity: PERGENE study; EUROPA trial; European; White. Significance metric(s): p = 0.011. Type of association: CO
|Drugs=perindopril
|Drug Classes=ACE INHIBITORS, PLAIN
|Diseases=Coronary Artery Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA165378309
}}

{{PMID Auto
|PMID=21846682
|Title=Association of angiotensin II type 1-receptor gene polymorphisms with the risk of developing hypertension in Mexican individuals.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}